ALPS GLOBAL HOLDING BERHAD partnering with CILO CYBIN to list Africa’s first Cannabis on Main Board of Johannesburg Stock Exchange (JSE)

ALPS had announced last month the underwriting exercise for CILO’s Special Purpose Acquisition Company (SPAC) for listing in Johannesburg Stock Exchange.

With this underwriting exercise, ALPS will be able to develop more drugs for medical purpose to serve the humanity. The company positions itself as a disruptive international health solutions company that focuses on an individual’s wellness, performance, and longevity goals.

ALPS’ Founder and Group CEO, Dr Tham Seng Kong had visited the CILO’s plant (pharmaceutical) at Johannesburg, South Africa in December 2022. This pharmaceutical company was GACP and GMP certified since year 2020, making CCP the first company in South Africa to have both GACP and GMP cannabis licenses in one company.

On the other hand, ALPS business focus is on the perception that the use of precision & preventive medicine as therapeutic entities will drive one of the next most important phases in medicine and wellness. ALPS has the leading edge technology & the necessary expertise (scientists, technological resources, researchers & equipment) all in place, all cutting edge, advancing with momentum. ALPS is currently one of the most progressive Biomarker Precision Diagnostic Lab with full instrument WGS Provider and cGMP stem cell cultivation in the ASEAN region, with a business focus on molecular cells as therapeutic entities.

ALPS trusts the collaboration with CILO will lay a firmer foundation between both parties, not only on developing more drugs for future medical purpose to serve the humanity, but also on ushering CILO closer towards the IPO in Johannesburg Stock Exchange (JSE).